News
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India
The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes® initiative to China and India, pledging $15 million over five years to help these developing nations with rapidly growing numbers of type 2 diabetes patients....
News
Serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis
Recently announced results from two-year CATT (Comparison of Age-related macular degeneration Treatment Trials) adds to the growing body of evidence, including CATT 1-year data and two retrospective database analyses, suggesting serious safety concerns associated with the use of...
News
AstraZeneca to acquire Ardea Biosciences for $1 billion
AstraZeneca and Ardea Biosciences, Inc. have entered into a definitive merger agreement, pursuant to which AstraZeneca will acquire Ardea, a San Diego, California-based biotechnology company focused on the development of small-molecule therapeutics. Ardea's clinically most advanced product candidate, lesinurad...
News
Key protein responsible for controlling nerve cell protection
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by...
News
Rosetta wins European patent covering core element of microRNA technology
Rosetta Genomics has won a European patent covering the use of miR-34a in the preparation of pharmaceuticals used to treat p53-negative cancers. The patent covers a core element of Rosetta's microRNA technology in the...
News
Women don’t receive the same treatment as men for heart disease the world-over
Women with acute coronary syndrome (ACS) receive inferior or less aggressive treatment compared to men, according to three large studies presented today at the World Congress of Cardiology. The CREATE registry study of 20,468...
News
Advances in personalized medicine for lung cancer
Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva. "A major...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.